Yield10 Bioscience, Inc. (YTEN) Misses Q2 EPS by 1c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q2 EPS of ($0.70), $0.01 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c